KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Amneal Pharmaceuticals (AMRX) Shares Issued (2017 - 2026)

Amneal Pharmaceuticals has reported Shares Issued over the past 8 years, most recently at $553000.0 for Q4 2025.

For Q4 2025, Shares Issued rose 266.23% year-over-year to $553000.0; the TTM value through Dec 2025 reached $2.0 million, up 69.84%, while the annual FY2025 figure was $2.0 million, 69.84% up from the prior year.
Shares Issued for Q4 2025 was $553000.0 at Amneal Pharmaceuticals, down from $653000.0 in the prior quarter.
Over five years, Shares Issued peaked at $685000.0 in Q2 2025 and troughed at $5000.0 in Q2 2021.
A 5-year average of $298823.5 and a median of $153000.0 in 2021 define the central range for Shares Issued.
On a YoY basis, Shares Issued climbed as much as 13420.0% in 2021 and fell as far as 96.73% in 2021.
Year by year, Shares Issued stood at $19000.0 in 2021, then soared by 2126.32% to $423000.0 in 2022, then tumbled by 89.83% to $43000.0 in 2023, then skyrocketed by 251.16% to $151000.0 in 2024, then soared by 266.23% to $553000.0 in 2025.
Business Quant data shows Shares Issued for AMRX at $553000.0 in Q4 2025, $653000.0 in Q3 2025, and $685000.0 in Q2 2025.